Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    Menu

    Prestwick2_001109

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,605Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bioversys Reveals Key Financials and Highlights for H1 2025
    Bioversys Reveals Key Financials and Highlights for H1 2025

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147471/0/en/Bioversys-Reports-Corporate-Highlights-and-Key-Financials-For-the-First-Half-2025.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    RedHill gets $1.1M in Talicia® licensing payments
    RedHill gets $1.1M in Talicia® licensing payments

    18 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-received-talicia-licensing-payments-totaling-1-1-million-302532195.html

    PR NEWSWIRE
    18 Aug 2025
    Share Share
    RedHill's Talicia Listed As First-Line For H. Pylori In ACG Guidelines
    RedHill's Talicia Listed As First-Line For H. Pylori In ACG Guidelines

    09 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhills-talicia-listed-as-first-line-choice-for-h-pylori-in-new-american-college-of-gastroenterology-guidelines-302241849.html

    PR NEWSWIRE
    09 Sep 2024
    Share Share
    RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia
    RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia

    06 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-biopharma-and-gaelan-medical-enter-into-license-agreement-for-talicia-for-the-united-arab-emirates-301455477.html

    PRNEWSWIRE
    06 Jan 2022
    Share Share
    ANI Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
    ANI Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP

    21 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211221005173/en

    BUSINESSWIRE
    21 Dec 2021
    Share Share
    Novitium Pharma's Generic Rifabutin Receives Approval in the U.S.
    Novitium Pharma's Generic Rifabutin Receives Approval in the U.S.

    17 Dec 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215041

    FDA
    17 Dec 2021
    Share Share